genedrive plc is focused on decentralising molecular diagnostics, concentrating on applications where our technology will provide sustainable growth
Diagnostics: Rapid and accurate diagnosis of infectious disease facilitating immediate therapeutic treatment.
Pharmacogenomics: Allowing medicine to be personalised around an individual patient's genotype.
Future applications: Genedrive® is being validated for use in the areas of pathogen detection & biosurveillance and aquaculture.
genedrive plc at a glance >
Share price details >
View all regulatory news >
26 November 2021
Final Results Presentation 30 June 2021
View all reports >
Wednesday January 05, 2022
Tesla, Boohoo and Scottish Mortgage among most popular private investors investments
Wednesday December 22, 2021
Caspian Sunrise climbs on positive production and financial update
Monday January 18, 2021
FTSE 100 finishes slightly lower amid thin volumes as Wall Street closed for Martin Luther King Day
View all news >
On the 8th June 2018 Genedrive Plc disposed of the business and assets of Epistem Ltd. Please follow this link to be redirected to the website of Epistem Ltd
© 2017-22 genedrive plc
Don't show this again